SHANGHAI, Jan. 7 /PRNewswire-Asia/ -- Sundia MediTech Company, Ltd., a
leading pharmaceutical R&D outsourcing Service Company in China, announced
that the company has been officially recognized as a technically-advanced
service enterprise in Shanghai. According to the related policy, the company
can get tax holidays in the future. This also demonstrates that Sundia's
strong service capability and advanced R&D ability, as well as its good track
record over the past several years, were well-recognized again by the Chinese
"We are pleased and honored to get this authorization, which is in
recognition of the efforts of Sundia's talented team and their hard work,"
commented Dr. Xiaochuan Wang, Chairman and CEO of Sundia Meditech. "This
authorization reflects our commitment to all of our customers. In the past 5
years, we have provided an integrated service of high-quality drug discovery
and development in a timely and cost-effective manner to our clients. We will
continue to provide the same excellent service in the future."
About Sundia MediTech:
Sundia MediTech Company is a leading integrated pharmaceutical contract
research organization (CRO) based in Shanghai, China. It was founded in
Shanghai in 2004 by a group of U.S. pharmaceutical industry veterans to
provide R&D outsourcing services to biotech and pharmaceutical companies
worldwide, ranging from chemical services, medicinal chemistry, biological
services, new technology platforms, and pharmaceutical development services.
SOURCE Sundia MediTech Company, Ltd.